BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6190112)

  • 21. Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol.
    Frye GD; Ellis FW
    Drug Alcohol Depend; 1977; 2(5-6):349-59. PubMed ID: 562250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.
    Kiianmaa K; Attila LM
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):165-70. PubMed ID: 574195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of monoamine neurotoxins on peptides in the rat spinal cord.
    Gilbert RF; Emson PC; Hunt SP; Bennett GW; Marsden CA; Sandberg BE; Steinbusch HW; Verhofstad AA
    Neuroscience; 1982 Jan; 7(1):69-87. PubMed ID: 6176903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats.
    Berger TW; Kaul S; Stricker EM; Zigmond MJ
    Brain Res; 1985 Jun; 336(2):354-8. PubMed ID: 3924346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of dopamine D2 but not D1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation.
    Dewar KM; Soghomonian JJ; Bruno JP; Descarries L; Reader TA
    Brain Res; 1990 Dec; 536(1-2):287-96. PubMed ID: 2150772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
    Waller SB; Buterbaugh GG
    Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine by 5,7-dihydroxytryptamine administered into various sites.
    Sawynok J; Reid A
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):1-8. PubMed ID: 2402297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: co-operative interactions of serotonin and dopamine in neostriatum.
    Waddington JL; Crow TJ
    Life Sci; 1979 Oct; 25(15):1307-14. PubMed ID: 316093
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term effects of 5,7-dihydroxytryptamine administered at birth on the development of brain monoamines.
    Lytle LD; Jacoby JH; Nelson MF; Baumgarten HG
    Life Sci; 1974 Sep; 15(6):1203-17. PubMed ID: 4549961
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure of spinal cord serotonin depletion to alter analgesia elicited from the periaqueductal gray.
    Johannessen JN; Watkins LR; Carlton SM; Mayer DJ
    Brain Res; 1982 Apr; 237(2):373-86. PubMed ID: 7083001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of regrowth of the bulbospinal serotonin system following 5,6-dihydroxytryptamine induced axotomy. I. Biochemical correlates.
    Björklund A; Wiklund L
    Brain Res; 1980 Jun; 191(1):109-27. PubMed ID: 6155167
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular effects of intracisternal 6-hydroxydopamine and of subsequent lesions of the ventrolateral medulla coinciding with the Al group of noradrenaline cells in the rabbit.
    Elliott JM; Stead BH; West MJ; Chalmers J
    J Auton Nerv Syst; 1985; 12(2-3):117-30. PubMed ID: 3923089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
    Waddington JL; Crow TJ
    Brain Res; 1979 Feb; 161(2):371-6. PubMed ID: 310332
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 Jun; 20(6):611-6. PubMed ID: 6972494
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.